Full Text
Cost-Utility Analysis Of Valsartan Versus Valsartan Plus Hydrochlorothiazide In Patients With Hypertension In The US

Abstract

Authors

P Pednekar

Back to Volume 21, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×